Viemed Healthcare, Inc. (NASDAQ: VMD) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 23.62 | EPS (ttm) | 0.38 | Insider Own | 13.13% | Shs Outstand | 38.09M | Perf Week | 1.37% |
| Market Cap | 339.37M | Forward P/E | 16.40 | EPS next Y | 0.54 | Insider Trans | -0.60% | Shs Float | 32.88M | Perf Month | -0.34% |
| Enterprise Value | 340.29M | PEG | 4.25 | EPS next Q | 0.12 | Inst Own | - | Short Float | 3.67% | Perf Quarter | -16.26% |
| Income | 14.42M | P/S | 1.13 | EPS this Y | 14.81% | Inst Trans | - | Short Ratio | 3.22 | Perf Half Y | -3.36% |
| Sales | 301.62M | P/B | 2.37 | EPS next Y | 31.45% | ROA | 7.10% | Short Interest | 1.21M | Perf YTD | 19.92% |
| Book/sh | - | P/C | 5.61 | EPS next 5Y | 29.20% | ROE | 10.30% | 52W High | 12.61 -29.34% | Perf Year | 36.66% |
| Cash/sh | - | P/FCF | 11.61 | EPS past 3/5Y | 35.11% -14.71% | ROIC | 11.00% | 52W Low | 6.05 47.27% | Perf 3Y | 23.92% |
| Dividend Est. | - | EV/EBITDA | 6.35 | Sales past 3/5Y | 24.77% 15.56% | Gross Margin | 57.21% | Volatility | 2.01% 2.77% | Perf 5Y | 43.25% |
| Dividend TTM | - | EV/Sales | 1.13 | EPS Y/Y TTM | 28.57% | Oper. Margin | 8.14% | ATR (14) | 0.26 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | Sales Y/Y TTM | 34.38% | Profit Margin | 4.81% | RSI (14) | 41.59 | Recom | 2.50 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.13 | EPS Q/Q | -12.50% | SMA20 | -0.11% | Beta | 1.03 | Target Price | 14.00 |
| Payout | 0.00% | Debt/Eq | 0.08 | Sales Q/Q | 23.81% | SMA50 | -11.25% | Rel Volume | 1.08 | Prev Close | 8.95 |
| Employees | 1,438 | LT Debt/Eq | 0.09 | Earnings | Nov 04 | SMA200 | -3.52% | Avg Volume | 383.21K | Price | 8.91 |
| IPO Date | Aug 09, 2019 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -41.67% 0.13% | Net Debt/EBITDA | 0.02 | Volume | 414,563 | Change | -0.45% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-24-26 | Initiated | Barrington | Outperform | $14 |
| Aug-06-26 | Downgrade | Freedom Broker | Buy → Hold |
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 301 | 270 | 224 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 129 | 115 | 91 | — | — | — | — | — | — | |
| Gross Profit | 172 | 155 | 133 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 143 | 130 | 112 | — | — | — | — | — | — | |
| Research and Development | 4 | 3 | 3 | — | — | — | — | — | — | |
| Other Operating Expense | 1 | 2 | 0 | — | — | — | — | — | — | |
| Operating Income | 25 | 21 | 18 | — | — | — | — | — | — | |
| Interest Expense | 1 | 1 | 1 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -1 | 2 | -1 | — | — | — | — | — | — | |
| Net Income Before Taxes | 21 | 22 | 16 | — | — | — | — | — | — | |
| Income Taxes | 6 | 6 | 5 | — | — | — | — | — | — | |
| Consolidated Net Income | 16 | 15 | 11 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 16 | 15 | 11 | — | — | — | — | — | — | |
| Net Income | 16 | 15 | 11 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.38 | 0.38 | 0.29 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.38 | 0.38 | 0.29 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.36 | 0.37 | 0.28 | — | — | — | — | — | — | |
| EBITDA | 54 | 52 | 42 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 24.75 | 20.08 | 28.64 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.12 | 1.07 | 1.40 | — | — | — | — | — | — | |
| Gross Margin | 57.14 | 57.41 | 59.38 | — | — | — | — | — | — | |
| Operating Margin | 8.31 | 7.78 | 8.04 | — | — | — | — | — | — | |
| Net Margin | 5.32 | 5.56 | 4.91 | — | — | — | — | — | — | |
| Shares Outstanding | 38 | 39 | 39 | — | — | — | — | — | — | |
| Market Capitalization | 339 | 290 | 313 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dobbs Randy E. | Director | Aug 19 '26 | Option Exercise | 0.00 | 20,954 | 0 | 146,444 | Aug 19 |
| Heltz Sabrina | Director | Aug 19 '26 | Option Exercise | 0.00 | 18,786 | 0 | 86,277 | Aug 19 |
| Kaushal Nitin | Director | Aug 19 '26 | Option Exercise | 0.00 | 18,786 | 0 | 161,361 | Aug 19 |
| Smokoff Timothy | Director | Aug 19 '26 | Option Exercise | 0.00 | 18,786 | 0 | 94,304 | Aug 19 |
| Frazier William | Chief Medical Officer | Jun 25 '26 | Option Exercise | 1.81 | 10,000 | 18,100 | 83,214 | Jun 26 |
| Frazier William | Chief Medical Officer | Jun 25 '26 | Sale | 11.72 | 10,000 | 117,200 | 73,214 | Jun 26 |
| Smokoff Timothy | Director | Jun 24 '26 | Sale | 11.50 | 20,000 | 229,967 | 75,518 | Jun 26 |
| Moore Michael | President | Mar 20 '26 | Sale | 8.77 | 65,000 | 570,050 | 1,585,812 | Mar 20 |
| Moore Michael | President | Mar 19 '26 | Sale | 9.21 | 40,232 | 370,537 | 1,650,812 | Mar 20 |
| Moore Michael | President | Mar 18 '26 | Sale | 9.42 | 31,570 | 297,389 | 1,691,044 | Mar 20 |
| ZEHNDER WILLIAM TODD | Chief Operating Officer | Jan 29 '26 | Option Exercise | 0.00 | 35,790 | 0 | 401,677 | Feb 02 |
| Hoyt Casey | Chief Executive Officer | Jan 29 '26 | Option Exercise | 0.00 | 53,060 | 0 | 364,377 | Feb 02 |
| Cambre Jerome | Vice President of Sales | Jan 29 '26 | Option Exercise | 0.00 | 11,492 | 0 | 106,961 | Feb 02 |
| Moore Michael | President | Jan 29 '26 | Option Exercise | 0.00 | 35,789 | 0 | 198,037 | Feb 02 |
| Trahan Jeremy | General Counsel | Jan 29 '26 | Option Exercise | 0.00 | 14,365 | 0 | 50,083 | Feb 02 |